معرفی
Dr Luan Luu is an early career post-doctoral research fellow at the Motor Neuron Disease Research Centre within Macquarie Medical School, Department of Biomedical Science at Macquarie University. His research focuses on developing therapeutics for neurodegenerative diseases, particularly Spinocerebellar Ataxia type 3 and ALS/FTD.
- Completed PhD at The University of Melbourne studying Amyloid Precursor Protein in Alzheimer's Disease
- Joined Angela Laird's lab at Macquarie University post-PhD
- Currently working on multiple active research projects related to TDP-43 pathology and neurodegeneration
Dr Luu's research centers on enhancing macroautophagy processes to degrade pathogenic misfolded proteins and restore cellular homeostasis. His work has significant implications for multiple neurodegenerative conditions involving protein misfolding, including Spinocerebellar Ataxia type 3, Huntington's disease, and other polyglutamine disorders. He has developed cellular models for screening potential therapeutics that could be trialed in animal models of these diseases.
His publication record shows consistent productivity with 17 research outputs since 2019, including articles in high-impact journals like iScience and Neurobiology of Disease, as well as multiple patents. His work demonstrates a clear progression from fundamental protein pathology to therapeutic development, with recent focus on TDP-43 phase separation and Cyclin F-mediated protein degradation pathways.
- Active participant in the Faculty of Medicine and Health Sciences EnCouRage Research Symposium (2017)
- Contributor to multiple collaborative research projects
- Research has been picked up by news outlets and shared across academic networks
Dr Luu's research program represents a significant contribution to understanding protein aggregation mechanisms and developing therapeutic approaches for currently untreatable neurodegenerative conditions. His collaborative approach across multiple projects demonstrates strong integration within the neurodegenerative disease research community.
